Sterling Pharma Solutions expands its transatlantic presence and development capabilities through acquisition of CiVentiChem in the US

London, UK – GHO Capital, the European specialist investor in healthcare, acknowledges today’s announcement from its portfolio company, Sterling Pharma Solutions, regarding the acquisition of CiVentiChem in the US. UK-based contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has announced its acquisition of CiVentiChem’s US facility located in Cary, North Carolina, US. The new… read more

Subscribe to our email alerts

Email updates